Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Scott N. COMPTON |
Documents disponibles écrits par cet auteur (2)
Faire une suggestion Affiner la recherche
Anxiety symptom trajectories from treatment to 5- to 12-year follow-up across childhood and adolescence / Sunhye BAI in Journal of Child Psychology and Psychiatry, 64-9 (September 2023)
[article]
Titre : Anxiety symptom trajectories from treatment to 5- to 12-year follow-up across childhood and adolescence Type de document : Texte imprimé et/ou numérique Auteurs : Sunhye BAI, Auteur ; Benjamin ROLON-ARROYO, Auteur ; John T. WALKUP, Auteur ; Philip C. KENDALL, Auteur ; Golda S. GINSBURG, Auteur ; Courtney P. KEETON, Auteur ; Anne Marie ALBANO, Auteur ; Scott N. COMPTON, Auteur ; Dara SAKOLSKY, Auteur ; John PIACENTINI, Auteur ; Tara S. PERIS, Auteur Article en page(s) : p.1336-1345 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : Objective The current study examined trajectories of anxiety during (a) acute treatment and (b) extended follow-up to better characterize the long-term symptom trajectories of youth who received evidence-based intervention for anxiety disorders using a person-centered approach. Method Participants were 319 youth (age 7-17?years at enrollment), who participated in a multicenter randomized controlled trial for the treatment of pediatric anxiety disorders, Child/Adolescent Anxiety Multimodal Study, and a 4-year naturalistic follow-up, Child/Adolescent Anxiety Multimodal Extended Long-term Study, an average of 6.5?years later. Using growth mixture modeling, the study identified distinct trajectories of anxiety across acute treatment (Weeks 0-12), posttreatment (Weeks 12-36), and the 4-year-long follow-up, and identified baseline predictors of these trajectories. Results Three nonlinear anxiety trajectories emerged: "short-term responders" who showed rapid treatment response but had higher levels of anxiety during the extended follow-up; "durable responders" who sustained treatment gains; and "delayed remitters" who did not show an initial response to treatment, but showed low levels of anxiety during the maintenance and extended follow-up periods. Worse anxiety severity and better family functioning at baseline predicted membership in the delayed remitters group. Caregiver strain differentiated short-term responders from durable responders. Conclusions Findings suggest that initial response to treatment does not guarantee sustained treatment gains over time for some youth. Future follow-up studies that track treated youth across key developmental transitions and in the context of changing social environments are needed to inform best practices for the long-term management of anxiety. En ligne : https://doi.org/10.1111/jcpp.13796 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=512
in Journal of Child Psychology and Psychiatry > 64-9 (September 2023) . - p.1336-1345[article] Anxiety symptom trajectories from treatment to 5- to 12-year follow-up across childhood and adolescence [Texte imprimé et/ou numérique] / Sunhye BAI, Auteur ; Benjamin ROLON-ARROYO, Auteur ; John T. WALKUP, Auteur ; Philip C. KENDALL, Auteur ; Golda S. GINSBURG, Auteur ; Courtney P. KEETON, Auteur ; Anne Marie ALBANO, Auteur ; Scott N. COMPTON, Auteur ; Dara SAKOLSKY, Auteur ; John PIACENTINI, Auteur ; Tara S. PERIS, Auteur . - p.1336-1345.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 64-9 (September 2023) . - p.1336-1345
Index. décimale : PER Périodiques Résumé : Objective The current study examined trajectories of anxiety during (a) acute treatment and (b) extended follow-up to better characterize the long-term symptom trajectories of youth who received evidence-based intervention for anxiety disorders using a person-centered approach. Method Participants were 319 youth (age 7-17?years at enrollment), who participated in a multicenter randomized controlled trial for the treatment of pediatric anxiety disorders, Child/Adolescent Anxiety Multimodal Study, and a 4-year naturalistic follow-up, Child/Adolescent Anxiety Multimodal Extended Long-term Study, an average of 6.5?years later. Using growth mixture modeling, the study identified distinct trajectories of anxiety across acute treatment (Weeks 0-12), posttreatment (Weeks 12-36), and the 4-year-long follow-up, and identified baseline predictors of these trajectories. Results Three nonlinear anxiety trajectories emerged: "short-term responders" who showed rapid treatment response but had higher levels of anxiety during the extended follow-up; "durable responders" who sustained treatment gains; and "delayed remitters" who did not show an initial response to treatment, but showed low levels of anxiety during the maintenance and extended follow-up periods. Worse anxiety severity and better family functioning at baseline predicted membership in the delayed remitters group. Caregiver strain differentiated short-term responders from durable responders. Conclusions Findings suggest that initial response to treatment does not guarantee sustained treatment gains over time for some youth. Future follow-up studies that track treated youth across key developmental transitions and in the context of changing social environments are needed to inform best practices for the long-term management of anxiety. En ligne : https://doi.org/10.1111/jcpp.13796 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=512 Symptom-specific effects of cognitive-behavioral therapy, sertraline, and their combination in a large randomized controlled trial of pediatric anxiety disorders / Matti CERVIN in Journal of Child Psychology and Psychiatry, 61-4 (April 2020)
[article]
Titre : Symptom-specific effects of cognitive-behavioral therapy, sertraline, and their combination in a large randomized controlled trial of pediatric anxiety disorders Type de document : Texte imprimé et/ou numérique Auteurs : Matti CERVIN, Auteur ; Eric A. STORCH, Auteur ; John PIACENTINI, Auteur ; Boris BIRMAHER, Auteur ; Scott N. COMPTON, Auteur ; Anne Marie ALBANO, Auteur ; Elizabeth GOSCH, Auteur ; John T. WALKUP, Auteur ; Philip C. KENDALL, Auteur Article en page(s) : p.492-502 Langues : Anglais (eng) Mots-clés : CBT/cognitive behavior therapy anxiety/anxiety disorders child/adolescent clinical trials pharmacotherapy Index. décimale : PER Périodiques Résumé : BACKGROUND: Pediatric anxiety disorders are highly prevalent and associated with significant functional disabilities and lifelong morbidity. Cognitive-behavioral therapy (CBT), sertraline, and their combination are effective treatments, but little is known about how these treatments exert their effects. METHODS: Using network intervention analysis (NIA), we analyzed data from the largest randomized controlled treatment trial of pediatric anxiety disorders (Child/Adolescent Anxiety Multimodal Study, NCT00052078, clinicaltrials.gov/ct2/show/NCT00052078) and outlined the causal symptom domain-specific effects of CBT, sertraline, and their combination over the course of the 12-week treatment while taking into account both specificity and overlap between symptom domains. RESULTS: All active treatments produced positive effects with the most pronounced and consistent effects emerging in relation to psychological distress, family interference, and avoidance. Psychological distress was consistently the most and physical symptoms the least central symptom domain in the disorder network. CONCLUSIONS: All active treatments showed beneficial effects when compared to placebo, and NIA identified that these effects were exerted similarly across treatments and primarily through a reduction of psychological distress, family interference, and avoidance. CBT and sertraline may have differential mechanisms of action in relation to psychological distress. Given the lack of causal effects on interference outside family and physical symptoms, interventions tailored to target these domains may aid in the building of more effective treatments. Psychological distress and avoidance should remain key treatment focuses because of their central roles in the disorder network. The findings inform and promote developing more effective interventions. En ligne : http://dx.doi.org/10.1111/jcpp.13124 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=421
in Journal of Child Psychology and Psychiatry > 61-4 (April 2020) . - p.492-502[article] Symptom-specific effects of cognitive-behavioral therapy, sertraline, and their combination in a large randomized controlled trial of pediatric anxiety disorders [Texte imprimé et/ou numérique] / Matti CERVIN, Auteur ; Eric A. STORCH, Auteur ; John PIACENTINI, Auteur ; Boris BIRMAHER, Auteur ; Scott N. COMPTON, Auteur ; Anne Marie ALBANO, Auteur ; Elizabeth GOSCH, Auteur ; John T. WALKUP, Auteur ; Philip C. KENDALL, Auteur . - p.492-502.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 61-4 (April 2020) . - p.492-502
Mots-clés : CBT/cognitive behavior therapy anxiety/anxiety disorders child/adolescent clinical trials pharmacotherapy Index. décimale : PER Périodiques Résumé : BACKGROUND: Pediatric anxiety disorders are highly prevalent and associated with significant functional disabilities and lifelong morbidity. Cognitive-behavioral therapy (CBT), sertraline, and their combination are effective treatments, but little is known about how these treatments exert their effects. METHODS: Using network intervention analysis (NIA), we analyzed data from the largest randomized controlled treatment trial of pediatric anxiety disorders (Child/Adolescent Anxiety Multimodal Study, NCT00052078, clinicaltrials.gov/ct2/show/NCT00052078) and outlined the causal symptom domain-specific effects of CBT, sertraline, and their combination over the course of the 12-week treatment while taking into account both specificity and overlap between symptom domains. RESULTS: All active treatments produced positive effects with the most pronounced and consistent effects emerging in relation to psychological distress, family interference, and avoidance. Psychological distress was consistently the most and physical symptoms the least central symptom domain in the disorder network. CONCLUSIONS: All active treatments showed beneficial effects when compared to placebo, and NIA identified that these effects were exerted similarly across treatments and primarily through a reduction of psychological distress, family interference, and avoidance. CBT and sertraline may have differential mechanisms of action in relation to psychological distress. Given the lack of causal effects on interference outside family and physical symptoms, interventions tailored to target these domains may aid in the building of more effective treatments. Psychological distress and avoidance should remain key treatment focuses because of their central roles in the disorder network. The findings inform and promote developing more effective interventions. En ligne : http://dx.doi.org/10.1111/jcpp.13124 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=421